Financial Highlights
Transition of consolidated financial results of the past 5 years
* Fiscal years ended March 31.
1. Consolidated management performance
| FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
FY ended Mar. 31, 2019 |
FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
||
|---|---|---|---|---|---|---|
| Net sales (¥ Million) | 19,194 | 20,350 | 21,289 | 21,465 | 20,466 | |
| Medical Instrument Division (¥ Million) | 11,373 | 11,537 | 11,641 | 12,232 | 11,081 | |
| Environmental Instrument Division (¥ Million) | 7,820 | 8,813 | 9,648 | 4,673 | 4,212 | |
| Particle Counter Division (¥ Million) | - | - | - | 4,558 | 5,172 | |
| Operating income (¥ Million) | 1,867 | 2,572 | 2,703 | 2,485 | 2,220 | |
| Medical Instrument Division (¥ Million) | 1,000 | 915 | 811 | 977 | 409 | |
| Environmental Instrument Division (¥ Million) | 866 | 1,656 | 1,891 | 538 | 476 | |
| Particle Counter Division (¥ Million) | - | - | - | 968 | 1,334 | |
| Ordinary income (¥ Million) | 1,957 | 2,651 | 2,789 | 2,577 | 2,297 | |
| Net income (¥ Million) | 1,480 | 1,887 | 2,002 | 1,779 | 1,636 | |
| Net income per share (J¥) | 114.72 | 153.76 | 163.14 | 144.96 | 133.27 | |
| Return on equity (%) | 8.0 | 10.1 | 9.9 | 8.2 | 7.1 | |
| Return on assets (%) | 7.6 | 9.9 | 9.9 | 8.8 | 7.6 | |
| Operating margin (%) | 9.7 | 12.6 | 12.7 | 11.6 | 10.9 | |
2. Consolidated financial position
| FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
FY ended Mar. 31, 2019 |
FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
|
|---|---|---|---|---|---|
| Total assets (¥ Million) | 25,919 | 27,795 | 28,476 | 29,850 | 30,683 |
| Net assets (¥ Million) | 17,962 | 19,572 | 21,043 | 22,232 | 23,726 |
| Equity ratio (%) | 69.3 | 70.4 | 73.9 | 74.5 | 77.3 |
| Book-value per share (¥) | 1,463.04 | 1,594.19 | 1,713.99 | 1,810.87 | 1,931.15 |
3. Consolidated condition of cash flows
(¥ Million)
| FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
FY ended Mar. 31, 2019 |
FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
|
|---|---|---|---|---|---|
| Cash flows from operating activities | 2,168 | 1,920 | 1,664 | 2,696 | 2,064 |
| Cash flows from investing activities | ∆562 | ∆695 | ∆756 | ∆969 | ∆1,137 |
| Cash flows from financing activities | ∆990 | ∆816 | ∆532 | ∆528 | ∆566 |
| Cash and cash equivalents at end of year | 3,479 | 3,888 | 4,263 | 5,467 | 5,826 |